Johnson & Johnson plans to invest $2 billion in manufacturing facilities in the United States.

Johnson & Johnson has pledged to invest $2 billion in North Carolina to enhance the drug manufacturer’s footprint in the United States.

President Donald Trump’s government’s decision to impose import fees on drugs will soon impact consumers’ wallets in the US.

Johnson’s board announced intentions to construct a new facility at Fujifilm Diosynth’s Holly Springs factory in North Carolina within the next decade.

The pharmaceutical leaders announced that approximately 120 new jobs will be generated by the expansion.